Annandale Capital’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.05M Sell
58,552
-2,000
-3% -$40.1K 0.17% 72
2025
Q4
$1.42M Sell
60,552
-10,000
-14% -$217K 0.23% 73
2025
Q3
$14.1M Sell
70,552
-5,000
-7% -$89.8K 0.25% 69
2025
Q2
$1.03M Hold
75,552
0.19% 72
2025
Q1
$836K Hold
75,552
0.16% 83
2024
Q4
$805K Hold
75,552
0.16% 80
2024
Q3
$960K Hold
75,552
0.19% 79
2024
Q2
$1.27M Sell
75,552
-6,000
-7% -$85.3K 0.26% 69
2024
Q1
$1.22M Sell
81,552
-279
-0.3% -$4.56K 0.28% 70
2023
Q4
$1.23M Hold
81,831
0.29% 76
2023
Q3
$1.15M Sell
81,831
-2,500
-3% -$40.1K 0.34% 62
2023
Q2
$873K Hold
84,331
0.25% 68
2023
Q1
$779K Hold
84,331
0.25% 65
2022
Q4
$748K Hold
84,331
0.25% 68
2022
Q3
$702K Hold
84,331
0.26% 70
2022
Q2
$691K Hold
84,331
0.27% 65
2022
Q1
$735K Sell
84,331
-1,923
-2% -$15K 0.29% 63
2021
Q4
$820K Hold
86,254
0.36% 61
2021
Q3
$1.45M Hold
86,254
0.87% 28
2021
Q2
$1.32M Hold
86,254
0.79% 31
2021
Q1
$1.68M Hold
86,254
1.19% 23
2020
Q4
$1.55M Buy
+86,254
New +$1.81M 1.3% 22

Other funds holding URGN